Search

Author/Creator Russell, Muir

1. Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects. Issue 6 (16th April 2018)

Authors:
Palmér, Robert; Mäenpää, Jukka; Jauhiainen, Alexandra; Larsson, Bengt; Mo, John; Russell, Muir; Root, James; Prothon, Susanne; Chialda, Ligia; Forte, Pablo; Egelrud, Torbjörn; Stenvall, Kristina; Gardiner, Philip
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 104:Issue 6(2018)
Page Start:
1155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284. Issue 7 (3rd March 2020)

Authors:
Asimus, Sara; Palmér, Robert; Albayaty, Muna; Forsman, Henrik; Lundin, Christina; Olsson, Marita; Pehrson, Rikard; Mo, John; Russell, Muir; Carlert, Sara; Close, David; Keeling, David
Journal:
British journal of clinical pharmacology
Issue:
Volume 86:Issue 7(2020)
Page Start:
1398
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P2‐002: Assessment of The Safety, Tolerability, Pharmacokinetics, and Effects on Plasma and Cerebrospinal Fluid AB Peptides of AZD3293, a Novel Bace1 Inhibitor, in Healthy Japanese Adults. (1st July 2016)

Authors:
Yoshihara, Tatsuya; Sakamoto, Kei; Matsuki, Shunji; Matsuguma, Kyoko; Uchida, Naoki; Azuma, Fumihiko; Russell, Muir; Hughes, Glen; Haeberlein, Samantha Budd; Alexander, Robert C.; Kugler, Alan R.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 12
Page Start:
P608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction. Issue 3 (2nd May 2021)

Authors:
Nelander, Karin; Lagerstrom‐Fermer, Maria; Amilon, Carl; Michaëlsson, Erik; Heijer, Maria; Kjaer, Magnus; Russell, Muir; Han, David; Lindstedt, Eva‐Lotte; Whatling, Carl; Gan, Li‐Ming; Ericsson, Hans
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 3(2021)
Page Start:
812
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides. (15th June 2017)

Authors:
Sakamoto, Kei; Matsuki, Shunji; Matsuguma, Kyoko; Yoshihara, Tatsuya; Uchida, Naoki; Azuma, Fumihiko; Russell, Muir; Hughes, Glen; Haeberlein, Samantha Budd; Alexander, Robert C.; Eketjäll, Susanna; Kugler, Alan R.
Journal:
Journal of clinical pharmacology
Issue:
Volume 57:Number 11(2017)
Page Start:
1460
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗